Raw data for: Structure-Based Repurposing of FDA-Approved drugs Reveals Dual MAPK and PPG Inhibitors in Leishmania donovani

Zenodo (CERN European Organization for Nuclear Research) 2026 Open access

Read full text
Authors: Aviral Kaushik
DOI: 10.5281/zenodo.18204762
Cited by: 0

Abstract

This file contains the raw data for: Structure-Based Repurposing of FDA-Approved drugs Reveals Dual MAPK and PPG Inhibitors in Leishmania donovani. The zip file also contains a readme file for reference.

Fields of Study & Subjects

Computational Drug Discovery Methods Research on Leishmaniasis Studies Protein Tyrosine Phosphatases

Publication details

Journal / source
Zenodo (CERN European Organization for Nuclear Research)
Publication date
1 October 2026